Brand names appearing in this publication are for product identification purposes only. No endorsement is intended, nor is criticism implied of similar products not mentioned. K-State Research and Extension is an equal opportunity provider and employer. Follow this and additional works at: https://newprairiepress.org/kaesrr Part of the Other Animal Sciences Commons Recommended Citation Recommended Citation Myers, A J.; Bergstrom, J R.; Ratliff, B W.; McKilligan, D M.; Tokach, Michael D.; Goodband, Robert D.; DeRouchey, Joel M.; Nelssen, Jim L.; and Dritz, Steven S. (2011) "Effects of Liquitein on weanling pigs administered a Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae vaccine strategy," Kansas Agricultural Experiment Station Research Reports: Vol. 0: Iss
Introduction
Weaning poses new challenges to the young pig such as a sudden change in diet and navigating social hierarchy. Consequently, postweaning pigs typically do not eat large quantities of feed in the first 24 to 72 h, which becomes problematic because sufficient nutrient intake is imperative to maintain gut integrity. To further compound the issue, anecdotal field reports have indicated that producers are having increased difficulty starting and maintaining weaned pigs on feed. These reports seem to have correlated with the wide-scale vaccination of weaned pigs for PCV2. Subsequent research trials at Kansas State University have indicated that PCV2 and M. hyo result in reduced nursery growth rate because of reduced feed intake (Kane et al., 2009 4 ; Potter, 2010 5 ).
Spray-dried animal plasma has been shown to improve both growth performance and feed intake in newly weaned pigs. Previous research has indicated that providing watersoluble plasma improved growth performance in newly weaned pigs (Steidinger et al., 2002) 6 . Liquitein, a new product, recently has become available. Liquitein is a highdensity, ready-to-use source of plasma and digestible energy. It is shelf-stable and can be administered through water lines during the weaning period or other times of low feed intake and stress; therefore, our hypothesis was that providing nutrients through the water may be an effective method in combating postvaccination feed intake reduction. The objective of the study was to evaluate the effects of Liquitein and a PCV2 and M. hyo vaccine regimen on growth performance of nursery pigs.
Procedures
All practices and procedures used in these experiments were approved by the Kansas State University Institutional Animal Care and Use Committee.
A total of 180 nursery pigs (C327 ×1050, PIC, Hendersonville, TN) with an initial BW of 12.6 ± 0.22 lb and 19 ± 2 d of age were used in a 35-d study. Pigs were transported approximately 7 h (387 miles) from the sow farm to the K-State Segregated Early Weaning facility in Manhattan. The facility is a totally enclosed, environmentally regulated, mechanically ventilated barn with 40 12.9 ft 2 pens located over metal tribar flooring. Each pen housed 5 pigs and provided 3.2 ft 2 floor space per pig. Pigs were provided unlimited access to feed and water via a 4-hole dry self-feeder (17.3 in.) and 1-cup waterer.
After arrival to the segregated early weaning facility, pigs were allotted to 1 of 4 treatments arranged in a 2 × 2 factorial with main effects of Liquitein (with or without) and a PCV2 and M. hyo vaccine regimen (vaccinates or non-vaccinates) with 5 pigs per pen and 9 pens per treatment.
Liquitein was provided to the pigs via water medicators (Select Doser 640; Genesis Instruments, Elmwood, WI) set at a ratio of 50:1 (50 parts water to 1 part Liquitein) for the first 5 d after arrival to the nursery. Liquitein is a ready-to-use product, which allowed for the water medicator to draw Liquitein directly out of the container using peristaltic action to pump the product into the water. For all treatments, waterers were shut off until the pigs were allotted and placed into their respective pens for the experiment. After allotment, Liquitein treatment waterers were flushed until Liquitein appeared in the cup. For the duration of the Liquitein treatment, the container with the Liquitein was weighed daily and usage recorded. Lines distributing Liquitein were flushed daily to ensure a constant supply of product.
On d 0 (weaning), pigs in the vaccinate group were given a full dose (2 mL) each of ResprisureOne and Circumvent. Again on d 21, pigs in the vaccinate group were administered a second full dose (2 mL) of Circumvent. All vaccines were administered as separate intramuscular injections according to label directions.
Common 3-phase diets were fed for the duration of the trial (Table 1) . Phase 1 diets were fed from d 0 to 5 and were in pellet form. Phase 2 and 3 diets were fed from d 5 to 21 and d 21 to 35, respectively, and were in meal form. Pigs were weighed on d 0, 2, 5, 7, 14, 21, 23, 25, and 35 . Feed disappearance was measured on d 0, 1, 2, 3, 4, 5, 7, 14, 21, 22, 23, 24, 25, and 35 . The frequent weighing and feed intake measurements were done to determine the immediate effects of vaccine administration. These measurements were used to calculate ADG, ADFI, F/G, and DMI.
Data were analyzed as a 2 × 2 factorial in a completely randomized design using the PROC MIXED procedure of SAS (SAS Institute Inc., Cary, NC). Pen was used as the experimental unit. When significant interactions (P < 0.05) were observed, least significant differences (LSDs) were the method used to separate the means. Results were considered significant at P ≤ 0.05.
Results and Discussion
No vaccine × Liquitein interactions were observed for ADG or F/G for the duration of the study (Table 2) .
One objective of our study was to evaluate ADG and ADFI immediately following administration of PCV2/M. hyo vaccination. To achieve this, we measured ADFI daily for 5 d after the first ResprisureOne and Circumvent (d 0) and second Circumvent vaccination (d 21). By d 3, pigs in the non-vaccinate group had increased (P < 0.05) ADFI compared with pigs in the vaccinate group (Figure 1) . On d 4, a vaccine × Liquitein interaction (P < 0.05) was observed for ADFI. The interaction is a result of nonvaccinate pigs that did not receive Liquitein via their drinking water having increased ADFI compared with all other treatments. On d 7, a vaccine × Liquitein interaction (P < 0.05) for ADFI was observed where pigs in the vaccinate group who had not been previously administered Liquitein demonstrated increased ADFI compared with all other treatments. Average daily gain (data not shown) was affected by dehydration of the pigs during transportation (approximately 7 h from IL) to the facility.
From d 0 to 5, the period immediately following the first injection, a tendency (P = 0.07) was observed for pigs administered PCV2/M. hyo vaccine regimen to have decreased ADG compared with the non-vaccinate group. Although not significant, pigs administered Liquitein during this period had a numerical tendency (P = 0.11) for increased ADG and dry matter ADFI (DMFI).
From d 5 to 21 and 0 to 21, pigs administered PCV2/M. hyo vaccine regimen had decreased (P < 0.05) ADG compared with pigs in the non-vaccinate group. No significant differences were observed for Liquitein.
From d 21 to 25, pigs administered PCV2/M. hyo vaccine regimen had lower (P < 0.01) ADG and ADFI compared with pigs in the non-vaccinate group. As a result of the reduced feed intake, a tendency (P < 0.07) was measured for pigs administered PCV2/M. hyo vaccine regimen to have decreased F/G compared with pigs in the nonvaccinate group. No significant differences were observed for Liquitein.
The stress of diet change and vaccination could perhaps explain the decrease in growth performance seen from d 21 to 23 and 23 to 25, where pigs administered PCV2/M. hyo vaccine regimen had decreased (P < 0.05) ADG compared with pigs in the non-vaccinate group (Figure 2) . On d 23 and 35, pigs in the non-vaccinate group had increased (P < 0.05) ADFI compared with pigs in the vaccinate group (Figure 3) .
From d 21 to 35, pigs administered PCV2/M. hyo vaccine regimen had decreased (P < 0.01) ADG and ADFI compared with pigs in the non-vaccinate group. Pigs previously administered Liquitein had increased (P < 0.05) ADFI compared with pigs that were not provided Liquitein. Why pigs previously administered Liquitein had increased ADFI during this period is unclear; however, other studies that have evaluated Liquitein also have observed the same postadministration increase in ADFI (unpublished data). Several theories have evolved regarding the increase in ADFI observed post-Liquitein administration. Perhaps Liquitein aids in maintaining the gut brush border, helping to boost immunity and consequently improve the piglet's ability to handle the stress of the second vaccination.
Overall, no significant differences were observed for Liquitein. Pigs administered PCV2/M. hyo vaccine regimen had decreased (P < 0.01) ADG and ADFI compared with pigs in the non-vaccinate group.
In conclusion, administering Liquitein during the first 5 d in the nursery increased feed intake later in the nursery stage (d 21 to 35), but the response was not great enough to influence overall growth performance; however, pigs administered the PCV2 and M. hyo vaccine regimen had decreased ADG and ADFI. 
